Heron Therapeutics
HRTX
#10254
Rank
ยฃ39.56 M
Marketcap
ยฃ0.21
Share price
-3.26%
Change (1 day)
-75.59%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2026 (TTM): -ยฃ0.14

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ0.14. In 2025 the company made an earnings per share (EPS) of -ยฃ0.09140 a decrease over its 2024 EPS that were of -ยฃ0.06855.

EPS history for Heron Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.1455.45%
2025-ยฃ0.0914033.33%
2024-ยฃ0.06855
2022-ยฃ1.32-23.11%
2021-ยฃ1.71-10%
2020-ยฃ1.90-0%
2019-ยฃ1.901.21%
2018-ยฃ1.88
2016-ยฃ3.4754.76%
2015-ยฃ2.241.73%
2014-ยฃ2.20-16.23%
2013-ยฃ2.6391.67%
2012-ยฃ1.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
SurModics
SRDX
-ยฃ0.94 547.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
ยฃ0.27-284.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ1.97-1,463.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
-ยฃ0.0000000000-100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Nektar Therapeutics
NKTR
-ยฃ5.10 3,426.32%๐Ÿ‡บ๐Ÿ‡ธ USA